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Although the evolution of the food and agricultural system in developed countries seems
to be progressing at an ever-increasing rate, in reality this trend has largely been realized as
small bursts of progress followed by relatively dormant periods until another break-through is
achieved. These break-throughs occur in a variety of ways, including the scientific, such as
the development of new hybrids and genetic lines, useful chemicals etc., the political, such as
the opening of trade with China and other communist countries, and the behavioral changes
such as the shift toward leaner meats, more natural food products, and more highly processed
"heat and serve" preferences among consumers.
Many of these changes have had profound effects on our way of life and in the products
which are now available for purchase. Some of these include:
a.) the mechanization of agriculture with its resulting shift of population from rural to
urban areas.
b.) antibiotics in animal health and nutrition with the resulting increases in resource
productivity and the enabling of large scale production units.
c.) hybridization of corn and other plant species resulting in dramatic increases in
productivity both here and abroad, (the Green Revolution in LDC's)
d.) refrigeration and storage techniques which have resulted in less waste and the
.availability of seasonally produced commodities year round.
e.) the development of chemical fertilizers and pest control which have had the dual impacts
of increasing yields while reducing the risks of production.
As we scan the present and look to the future, biotechnology with its recombinant DNA
procedures, gene transfers, embryo manipulation and transfer, etc.. appears to be the location
on the broad frontier of agricultural progress where the next burst of change is most likely to
occur. Some of these changes, born of biotechnology, are already reaching the commercial
2marketplace in animal agriculture, with the major plant developments likely to come
significantly later.
The major biotechnology innovations which have had some press coverage include the
bovine growth hormone which stimulates increased milk production, and the ice-minus bacteria
which reduce strawberry plants susceptibility to freezing weather, but these are merely the tip
of the biotech iceberg which will gradually emerge over the next 10-20 years. Likely
possibilities include significant improvements in feed efficiency and reduced fat content of
meats due to growth hormones, herbicide resistant, pest resistant, and viral resistant plants
through gene transfers, and improved nutrition, taste, texture, or shelf life in fruits,
vegetables, oilseeds, etc.. Generally these new developments can probably be classified as
production-increasing (e.g. more production per animal or acre), cost-reducing (e.g. less input
required for some output), risk-reducing, (e.g. less susceptibility to disease), or quality-
improving (e.g. less saturated fats in oilseeds), or new-product-generating (e.g. a new product
clearly distinct from existing products).
There is little doubt that these developments will have significant impacts, directly or
indirectly, on a broad spectrum of participants in the food and agricultural sector. Since we
are all consumers of food, that means we're all involved to some extent. Participants most
likely to be dramatically affected in the private sector include farmers, farm supply companies
such as feed, seed, and farm chemical dealers, farm credit agencies including banks and lending
institutions, companies developing biotechnological products, food processors and merchandisers
of food, fiber and animal products.
Those involved in the public policy and regulatory process will play a major role in
responding to these developments while encouraging or restraining biotechnique through the
political process and allocation of funding. Economists will play a major role in this process
by providing input to these decision-makers regarding the economic impacts of biotechnology.
3In this paper, we consider some of the more provocative economic issues regarding
potential biotechnological developments and then briefly outline the analytical approaches which
economists might use to address the economic and social tradeoffs of innovations prior to their
commercial realization.
The Ethical Dimension
Most economists, by training, conceive of themselves as dispassionate purveyors of value-
free facts who provide information to policy makers. These policy-makers, in turn, use these
facts to make the kind of value-laden decisions concerning what ought to be in a society.
This view of the role of economists in the life of a society is gradually giving way to a more
realistic perception. The methods used by economists to model human behavior and predict the
impacts of various potential developments (whether in biotechnology or other areas) have
inescapable moral or ethical dimensions. Since all economic models and methods are essentially
reductionist in nature, they require both implicit and explicit value judgments regarding the
nature of the individual, the components of the biological and socioeconomic process that ought
to be considered in the model and the analytical process, and the ultimate weighting or valuing,
usually in monetary terms, of the measures of performance. Inasmuch as the results of these
models are used to create reality by their implementation in the world, economists bear some
of the responsibility and ethical burden for the reality they help to create.
In their recent pastoral letter. Economic Justice for All. the U.S. Catholic bishops suggest
that the ethical notions of economic decisions can be judged in light of three basic questions:
"What does the decision and its implementation do ifi people?", "for people?", and "how does it
allow them to participate?". In economic terms, the first two questions involve measuring the
costs of economic decisions and their returns or benefits respectively. These are standard
questions which economists deal with every day, and which we focus on in this paper. The
third question is not easily dealt with in current, economic thinking but seems to have
4something to do with the basic right of individuals and communities to substantively participate
in their own economic destiny — i.e. that the process has some utility above and beyond the
economic results per se.
Econpmic Issues
Productivity Enhancement in Surplus Situations
Should biotechnology innovations which enhance productivity be ignored, banned, or
subsidized by the public sector in industries facing surpluses? The European Economic
Community has banned growth hormones for a number of reasons, including the fact that they
have large surpluses as a consequence of their highly protective agricultural policies. Some
Wisconsin farmers have picketed at the University of Wisconsin, demanding no research on the
bovine growth hormone. On the other hand, public university research on biotechnology is
supported by public funds in many states in the U.S..
Should the fact that an industry is facing surpluses deter support of biotechnology
research or advances in that industry? Generally, large persistent surpluses are found only in
industries with artificially-maintained prices , artificially-maintained by government intervention
in the market system. In some cases, those surpluses are maintained by design to protect
against weather vagaries like those that created the world food crisis in 1973-74. In other
cases, they the product of political power or mistakes.
Generally, one could argue that trying to hold back technological advance is like trying to
hold back the tide. In addition, enhancing productivity and reducing costs generally allows an
industry to become more competitive in serving its ultimate customer, here and abroad. In
situations where surpluses are present because of government intervention, reducing production
costs should allow legislators to lower the level of price protection and maintain the same level
of income protection, while reducing the consumer price, enhancing consumer demand, and
improving the potenti^ long run,viability of the industry. Usually surpluses are a temporary
5situation, while biotechnology advances are long term in nature, so the current situation should
not be the primary determinant of the desirability of biotechnological research or products.
Structure of Agriculture
Regardless of existing surpluses, many question whether biotechnology applied to
agriculture will automatically result in a reduction of small to medium-sized farmers with
concentration of production in the hands of fewer, larger-sized farms. To the extent that
biotechnology will speed the rate of farm productivity increase, it would seem likely that fewer
producers would be required unless increases in demand occurred at an equal or faster rate.
Who gets displaced will ultimately depend on who most quickly adopts these technologies. The
expectation would be that the higher-cost, least-competitive producer would be the first victim.
In those agricultural industries where economies of size are significant, the smaller, less
technologically sophisticated operators would tend to be the last adopters and the first
dropouts. A new round of structural adjustment seems inevitable.
if the exact character of agriculturally related biotechnology is capital-intensive, larger
size operations would be more likely to justify major capital expenditures than small operations,
and encourage smaller farmers to get bigger or get out. If no big investments are required,
size may not be as important as sophistication, but that still may favor larger farm operations
to some extent, since they can justify investing their time in gaining the required expertise to
use sophisticated new technology. Yet, biotech companies trying to sell new innovations to
farmers have a clear incentive to produce new products in the simplest form to expand their
potential market that could lead to little size discrimination in new technology adoption by
farmers. It is possible also, that some advances will be more labor-intensive, which could
stimulate rural employment. Others may ultimately enhance consumer demand and market share,
causing the producers of these products with improved nutrition, taste, texture, or shelf life to
increase in number at the expense of producers of other products. The only certain thing at
this stage is that the current situation will change. As pointed out, the aggregate nature of
6that change is not necessarily clear at this time, but it is an important issue that might be
analyzed as new biotechnologies emerge.
More interesting questions may arise if biotech companies find that new proprietary
products must be grown and produced under control, either involving farm ownership or the
more likely method of production contracting.. In the latter case, the market for contracts
would substitute for existing commodity marketing systems.
Further changes in crop characteristics could cause significant changes in climatic zones
with comparative advantages in some crops, and cause wholesale restructuring in production and
related processing industry location. While these are not likely in the near future, they
certainly could be possible later in the evolution of biotechnology. Changes in livestock or
crop product characteristics (e.g. leaner pork or vegetable oils with less saturated fatty acids)
or relative prices could also cause significant consumer product substitution and demand shifts,
and cause significant shifts in consumer market shares and related production patterns in some
commodity market strategic groups. Significant product characteristic changes or new,
competitive products create significant shifts in various commodity production and processing
industry volumes, location, and economic viability.
Primary Beneficiaries of Biotechnology
Many question who will be the primary beneficiaries of biotechnological advancements.
The corollary question is who will be the primary losers as these advancements are realized?
Clearly, the biotech companies that develop an innovative product with patent protection should
be expected to share in the economic benefits that the new product offers its purchasers. In
some cases, other companies selling complementary products may also benefit, especially if a
plant is designed to use that product most effectively relative to its competitors (e.g. a plant
resistant to a specific herbicide).
7There is a large element of risk in long-term development, with few efforts ultimately
succeeding from the many projects begun by scientists. Large research and development costs
over the previous decade must be recaptured, plus investments in production facilities, etc.. The
amount of payback will depend on the economic benefit generated for users of the new
products, the degree of competition currently or potentially in that market, and the share of
the benefits necessary to pass on to the farmer in order to make the new product a viable
commercial business.
!
Farmers are the likely target customers for most agricultural biotechnology products, but
there will have to be a clear economic incentive for the farmer to buy the new product and
modify die production process. Whether the new product is yield-increasing, cost-reducing,
risk-reducing, or quality-enhancing, the farmer^s perceived value of the performance changes
will have to be greater than the associated costs to get any significant market volume. For
example, animal health product companies typically find that beef or hog producers require a
minimum of $2.50 - 3.00 increase in revenue before theyUl pay $1.00 for the improved input,
while broiler producers may require much less.
Farmers who first adopt new biotech products are likely to get the primary benefits of
temporarily above-normal profits as their costs per unit decline or benefit from improved
quality. As their neighbors also adopt the improvements, excess profits begin to erode as
farmers expand production; the net result is falling prices for output and additional structural
change due to another cost-price squeeze until near perfect competitive levels are once again
achieved. Even if a minority of farmers adopt the new technology, they may control enough
production to shift the industry supply curve to affect market prices and profit levels
significantly. Non-adopters would be more likely to have low profits or losses, and may be
forced to adopt significant technical advances or drop out. This is the so-called technological
treadmill, — taking on the newest technology just to maintain the profit status quo.
8Consumers, not farmers, ultimately are the primary beneficiaries of technological
improvements in agriculture. This benefit is realized in higher quality food products, and lower
food prices. Industries within the agricultural sector which most improve their technology and
their cost relative to perceived value also have a clear advantage in competing for the
consumers food dollar. The poultry industry is an excellent example of this. The tremendous
increase in efficiency of poultry production, and lower relative prices coupled with behavioral
changes in consumer diets has resulted in a rapid increase in per-capita consumption and
(
market share in the last three decades.
Yet, there are some aspects of biotechnological innovation where the benefits or costs are
not yet clear. For example, some crops can soon be genetically engineered to be resistant to
pests, which may reduce the need for some pesticides which may have detrimental
environmental or ecological effects, and significant economic benefits to the users. While the
apparent effects of this development or viral disease resistant plants would appear to be
beneficial, the effects of herbicide resistance which can now be genetically engineered into
some plants (e.g. tomatoes) is less clear. These obviously could benefit farmers with weed
problems and facilitate low tillage farming methods. Will farmers be more likely to spray more
chemicals as a consequence, or will yields be enhanced sufficiently that fewer acres would be
needed and fewer chemicals would be used? There are other biotechnological innovations being
designed to break up and remove chemicals (like PCB's) from contamination sites. The
individual and aggregate effects of some potential developments like these clearly will require
further study, but the potential for biotechnological advances to replace some current chemicals
used in food production and clear up some environmental problems seems potentially exciting.
If biotechnological advances expedite the rate of productivity improvement faster than
demand improvement in agricultural industries, then the type of changes in the structure of
agriculture and rural communities we've seen over the last few decades would be expected to'
continue, possibly at a more rapid pace, though not nearly as fast as in the 1980*s' with the
9farm financial crisis. For example, if the bovine growth hormone stimulates a 15% increase in
milk production when actually, that may mean a 10% increase per lactation, and reduce the
number of cows necessary to supply current milk needs (not nearly the 30-40% estimated in
early studies) only if every farmer adopted the technology. This effect would obviously be less
if many farmers did not adopt the technology, or prices where allowed to drop (but incomes
still be protected) to enhance dairy product demand. Some high cost dairy farmers would be
squeezed out of the dairy enterprise if government income supports were reduced, supply quotas
were imposed, or new dairy buy-out programs were initiated to restrict growing surpluses.
While some might leave farming, especially farm workers, others might stay in farming but shift
their labor and investment into different enterprises. It^s not likely to be as dramatic as the
financial demise of some farmers in the midwest in the 1980*s, where farmers lost their farm.
However, the extremes which we've experienced in the last several years also can give some
' perspective on the types of change resulting from technological change. These include a)
unemployment, at least transitionally, of dairy farmers and dairy farm workers as less labor
intensity is typically required in alternate farm enterprises, b) the write-off of dairy related
specialized capital in agriculture, c) the costs to local communities where dairy farming was
displaced.
The next-best enterprise characteristics in areas where dairy farmers would be squeezed
out or bought out are the primary determinants of the on-farm costs and the rural community
costs. If less labor intensive enterprises are second-best, greater underemployment or
unemployment would result, typically most painful for older, less well-educated persons, less
adaptable to training and new employment, and in communities with few other employment
alternatives. The social costs of the lower incomes or employment would be greatest for those
rural communities perched precariously close to the edge of the critical mass of population and
economic activity necessary to support major businesses, schools, recreation, and other
amenities. The aggregate impacts of such technological change on the quality of life, the
10
structure of rural communities, and other costs associated with changing form income and
employment are clearly factors which ought to be considered and measured. How to minimize
the costs of adjustment, and capitalize on the opportunities presented by technological change
is the challenge facing farmers and rural communities.
Change is a continually ongoing concern and does bear a key element in the United States
and other countries. Change carries with it impacts which are born by society. Some impacts
are in the form of benefits while others represent costs. Models are available for economic
analysis of changes. However, many have focused on an economic analysis of a change that
has already occurred. It is much more difficult to evaluate a priori a change that is on the
horizon. Data on expected adjustments etc. can be very sketchy making projections difficult.
None-the-less, it is imperative that a developed society have some notion of the consequences
of forthcoming technologies. It is necessary to have an informed judgement of likely impacts.
Analytical Approaches
Previous Studies
Before considering possible procedures for economic evaluation of biotechnology, we
briefly consider previous attempts to analyze technological advancements. We consider the
research approach used, the types and availability of data used, and assess how these
procedures may be applied to the current problems of determining the social and economic
impacts of biotechnology.
A key element in assessing the impacts of technology is estimating the rate of adoption
and diffusion of the technology through the user industry. A new technology has zero impact
if it is not adopted for use.
A landmark study which considered the mechanics of how technology is generated and
propagated in U.S. agriculture was conducted by Zvi Griliches in 1957. He evaluated the
process of hybrid seed com adoption in the U.S. using the data gathered after the adoption of
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hybrid seed corn. He plotted the adoption patterns and analyzed the cross-sectional differences
in the adoption of this technology. The model developed by Griliches, which is now widely
used, is as follows,
In (P / K-P) = a + bT
where,
P » adoption rate
i a - intercept
b = coefficient for T
T s year trend, i.e. year « l,2,...,n
K = upper limit of adoption rate, i.e. K « .95, .90, etc.
Griliches reported that a new variety was very slowly adopted by producers at the beginning
because of uncertainty associated with potential yields. However, the adoption rate increased
at an increasing rate as others viewed the success of the early adopters. This continued until
an upper limit was reached where some producers absolutely will not adopt the technology.
This results in an S-shaped adoption trend over time.
adoption % )
time
Griliches hypothesized the rate of acceptance and the ultimate equilibrium level of acceptance
were functions of the profitability of the technology. This hypothesis was confirmed by the
data available. The "profitability" hypothesis also is relevant for biotechnology.
Following this initial development of techniques for analysis of adoption of new
technologies, Griliches and others used the procedures to further analyze the impacts of
technology on society. Griliches proceeded to evaluate the net social impacts of hybrid seed
12
corn using the classical consumer-producer surplus techniques which will be discussed in more
detail in the analysis section. Societal impacts were based on data collected on research costs,
displacement of resources, and the returns from planting hybrid seed com. This same
procedure has been applied to several other innovations over the years, including the
•development of a tomato harvester (Schmitz), the development of hybrid strains of rice
(Evenson), and cotton (Ayer).
Although consumer-producer surplus analysis has been widely used, in 1983 Ito, Grant, and
Rister used dynamic econometric modeling techniques to assess the impacts of the development
of a high yielding rice variety. They began by udng the technique of adoption estimation
developed by Griliches, and then proceeded to use a dynamic, general equilibrium, deterministic
simulation model developed by Grant, Beach, and Lin to analyze the rice supply-demand sectors
and price relationships among producers, millers, and retailers. To estimate the impacts of the
new semi-dwarf varieties, the estimated adoption rates were integrated into the yield equations
of the simulation model, and then simulations were made with and without the semi-dwarf
varieties included. They estimated the impacts on acreage, yield, production, prices and
demand. Although the initial calculations were made using 3 years of previous data, the model
was used to project the impacts through 1990. This type of estimation provides another
interesting avenue for the prediction of the economic impacts of relatively new, but
commercially untested biotechnology.
Although these studies all provide some useful insights into ways of estimating the
economic impacts of biotechnology. It should be noted that each study cited was conducted on
an gx post basis. That is, in every case the technology already existed, and was at least being
used on a test basis. Biotechnology does not afford us this luxury. Many of the exciting
developments are still years from commercial availability, and even then, clearance for use is
uncertain, since the techniques are subject to approval by the EPA, FDA, USDA, and/or state
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agencies. This suggests that some innovative analytical techniques will be needed for
meaningful evaluation of the economic impacts of biotechnology on an a priori basis.
A very recent study which estimates the before-the-fact economic impacts of bovine
growth hormone (bGH) on the dairy industry was completed by Robert Kalter (1985). In the
analysis, Kalter made use of. a framework, similar to that of Griliches to evaluate the adoption
and diffusion pattern of bGH. However, Kalter used survey responses from dairy producers to
estimate the producers acceptance of the new technology. Once the adoption and diffusion
analysis was completed, Kalter proceeded to estimate the economic impacts by using linear
programming analysis which will be discussed in more detail in the analysis section. This is
the first extensive study which has been completed with respect to the economic impacts of
biotechnology, and offers a useful format for future studies.
Ex Ante Research Approaches
As with the historical analysis of technological innovation, it is necessary to begin a
meaningful analysis of the economic impacts of biotechnology by first addressing and estimating
the rate of adoption of the various biotechnological innovations which may be introduced.
Varying the extent of adoption will significantly change the magnitude of the economic and
related social impacts.
As mentioned previously, one useful technique to estimate the adoption and diffusion of
biotechnological innovations would be Griliches* framework. However, Griliches* study was
conducted long after the technology was introduced; thus it was possible to fit the model to
the historical data available, and then make estimates of the behavioral parameters of interest
using the model. However, the innovations made possible by biotechnology typically have not
occurred yet, and are sufficiently important that before-the-fact estimates of their likely
impact are necessary to contribute to the debate over their potential benefits and costs. The
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rate of adoption of the technologies will be dependent on the economic value of the benefits
derived, the capital requirements and variable costs of using the technology, the management
changes which may be required, and the perceived risk of using an unproven technology, as
well as how the producer perceives consumer acceptance of the final product on which some
type of biotechnology has been used. One possible way to address this problem is through
subjective producer surveys, wherein the producer is presented with a likely scenario of the
potential characteristics of the new technology, and then is asked whether the technology
would be acquired in various situations. Using this information, it may then be possible to
provide preliminary estimates of the adoption rates and ultimate market penetration which can
be anticipated for the given innovation.
Once a consensus estimate for the expected adoption of the innovation has been obtained,
it will be possible to proceed with the process of estimation of the economic impacts of the
innovation. Four methods which may provide useful information on which to base decisions
include econometric analysis, welfare analysis, mathematical programming, and the Delphi
technique. Although each technique may have its strengths and weaknesses, a brief description
of each technique, and the necessary alterations which must be made for their adaptation to an
a priori analysis of the impacts of biotechnology follows.
Econometric models
The first technique considered is econometric analysis. Econometrics is basically
concerned with explaining statistical relationships among economic variables. These
relationships are then used to explain production, allocation, and distribution decisions. But,
how might econometric techniques be applied to the issue of biotechnology?
Biotechnology innovations often are production-enhancing or cost-reducing processes using
biological methods. This would imply that these technologies will increase the commodity
supply. Econometric models which incorporate realistic biological and economic behavioral
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relationships of industry supply response would be an important component in estimating the
impacts of technological change.
Nearly all major agricultural commodities have been modeled using some type of dynamic,
general equilibrium econometric model. These models often involve supply-demand relationships,
aiid price relationships among producers, processors, and retailers. When using econometrics, it
must be remembered that adoption of biotechnology may have a twofold effect on shifting
historical trends. First, many innovations change the nature of production, that is, it changes
the biological constraints associated with production. Secondly, it may change the economic
relationships, such as cost of production, and level and types of inputs for production. Thus,
many of the available models of supply response must be modified extensively in order to
obtain reliable estimates of the impacts of the technology.
Although it is plausible to alter the specifications of the models to take account of the
changes outlined, another problem arises in^ that it is not possible to test the reliability of the
specifications of the model using standard statistical tests without historical data. However, an
analyst has to settle for the best information available, and that is likely to be experimental
data generated by universities and private companies, and the expert opinions of the
researchers developing and testing the biotechnology innovation. Then, the analyst can build
most likely scenarios, and use sensitivity analysis to qualitatively determine the confidence level
in the results.
Another consideration in using econometrics to model the impacts of biotechnology is the
cross-product effects many of these technologies will incur. For example, the use of growth
hormones in lean meat production not only affects the particular meat animal species in which
it is used, but may also have impacts on the demand for other substitute meat products. If
dramatic changes in fat content of red meats occur, broiler and turkey demand clearly could
change. Beyond that, since many growth hormones result in an increase in production
efficiency, demand for the feed inputs may also be affected, resulting in changes in grain
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prices, government feed grain program costs, and other similar factors. This example illustrates
that it will be necessary to build into each existing econometric model the cross product
demand relationships and input market linkages to generate a realistic dynamic model which
considers the interrelationships across markets.
Although econometrics lends itself rather well to analyzing microeconomic implications, it
is rather difficult to extend these results to evaluate societal impacts of biotechnology.
However, welfare analysis may aid in answering the macro type questions such as "do
consumers benefit from the development of the technologies at the expense of the producer?,"
or "do these innovations increase the wellbeing of everyone?".
Welfare Analysis
An economic approach to measuring the relative gains and losses from alternate states of
the economy is to determine changes the consumer-producer surplus. Consumer surplus is
defined as that area (b) above the price line (P*) and below the demand curve, while producer
surplus is defined as the area (a) above the supply curve and below the price line. These areas












D a demand curve
S S5 supply curve
P*, Q* = equilibrium price and quantity
a s producer surplus
b B consumer surplus
17
Thus, the surplus areas depend on the relative positions of the supply and demand curves, as
well as the slopes of the supply and demand curves.
In order to meaningfully apply this criteria* it is first necessary to have estimates of the
elasticities (slopes) of the supply and demand curves. Then, using data after the change has
occurred, it is possible to re-estimate the position of the curves, and then evaluate the changes
in producer and consumer surplus to see who has gained or lost under the new state.
Supply and demand curves are presently available for many of the commodities affected,
making the first part of the analysis relatively simple. The complicating problem is that
historical data to estimate the effects on the supply and demand curves from a change in
biotechnology are nonexistent. However, it is feasible to proceed with the estimation based on
the technical experimental data from field testing done to date.
Another problem in welfare analysis arises on the consumer side. It is not immediately
apparent how consumers will react to products which have been produced using genetic
engineering or other methods. It is not known if they will react positively to a product
available at a lower cost. Thus, it may be necessary- to do extensive consumer surveying or
market tests to determine what the effects of the use of biotechnology will be on product
preference. Again, this will be difficult to do a priori. However, it is possible to develop
alternative scenarios based on current information, and present these to consumers to attempt
to estimate how their product demand will shift. A better method would be developing
prototype products and labels, and observe consumer choices in a slightly more realistic
scenario.
Mathematical Optimization Programming Models
Mathematical programming is a tool frequently used to assess adjustments likely to result
from technologies still in the developmental stages. With this technique, a base is developed
18
for comparison. Information on the new technology is then incorporated to project likely
impacts.
Mathematical programming techniques range from linear programming, to integer
programming, to quadratic programming. Models are commonly developed around a profit
maximizing or cost minimizing objective function^
Mathematical programming requires development of a reasonable set of production and/or
cost parameters for the biotechnology being evaluated. As already suggested, this can be very
difficult at an early state of development. However, one advantage of mathematical
programming is the ease of changing expected yield levels, etc. It conveniently allows for a
"sensitivity analysis" of parameters to determine how sensitive results are to selected variables.
Through this approach a number of "what if questions can be addressed^ For example,
presume a new technology is being developed that will have a cost reducing impact on beef
production. However, the level of cost reduction is not fully understood but it is felt that it
is somewhere in the range of 50 to $2.00 per cwt. of beef. Once the model is developed it
does not require much time to run numerous scenarios. For example, scenarios for 50, $1.00,
$1.50, $2.00, $2.50 and $3.00 per cwt. reduction in beef production can be run to see what the
expected outcome is for different cost levels. This "sensitivity analysis" approach can be used
for any variable in the model.
An additional benefit of "sensitivity analysis" is that it allows determination of which
model parameters are sensitive to changes. For example, there may be disagreement on
expected production impacts of a new technology. A programming model may indicate that the
exact impact is not important as expected adjustments remain relatively stable over a wide
range of production impact levels.
A key advantage of mathematical programming is that unlike econometric estimation it
does not rely on historical data to establish expected trends, etc. It represents a current
model of the industry. However, results are only as good as the model and the embodied
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assumptions. It provides good evaluations of ultimate impact, but often is not a good projector
of the likely pattern of ch^ge over time. Recent examples of the use of mathematical
programming would include work at Cornell (Kalter et al.» Kalter and Milligan), Texas (Yonkers
et al.) and Iowa State (Boehlje et al.. Shin and Kliebenstein).
As with any approach, it is important not to take absolute numerical results from
programming models as the gospel truth. Their real contribution is the directions of change in
the results. An observation of an increasing or decreasing trend is of much greater value than
is the overall level of the change. Key model assumptions may have a significant impact on
the magnitude of the change. A magnitude which would be erroneous if the assumption is
flawed. While it is recognized that mathematical programming may not provide accurate
information on absolute shifts, we must not lose sight that programming is quite efficient in
projecting trends.
Also, impact evaluators must not fall into the trap of developing a complex model because
everybody else develops complex models. Many times sophisticated models are used with
unsophisticated data. Any model is only as good as the available data. When evaluating new
technologies on an a priori basis, much of the data has a degree of uncertainty around it. A
simplified approach to development of expected trends using available theory may be as
accurate and much less time consuming than a sophisticated model. It is not hard to think of
(
studies that have utilized a complex modeling procedure to determine expected trends. With a
little foresight and thought, a piece of paper, and two hours of time, would have produced the
same expected trends.
Delphi Technique
The final approach to assessing expected impacte of biotechnological discoveries which is
discussed in this paper is that of expert opinion, or the Delphi technique. With the Delphi
technique information is usually obtained from individuals most knowledgeable of the
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technology. This information would include its probability of being successfully developed, and
its impact on yield levels, etc., if adopted. This can be an effective method of establishing a
range of values for uncertain data that may be used in other techniques such as mathematical
programming. Through mail, telephone, or on-site interviews, experts can provide information
on potential technological innovations, expected production impacts, etc. Some researchers
have used a two or three stage Delphi technique. The first stage is an information gathering
phase with the following phases used to gain information on the level of confidence responders
have in their responses. With this technique years of experience and knowledge from working
with the product are captured, along with any biases that the experts may have.
Summary
In conclusion, we have identified a few of the issues or questions which often arise about
biotechnology, and traced some of the likely implications and unresolved issues regarding
biotechnology. We suggest that short term surpluses, especially those that are due to
government Intervention, should not be a major factor determining biotechnology advances or
restricting research. Secondly, we expect that the structure of agriculture may continue to
evolve toward larger scale operations, but that biotechnology advances are not necessarily going
to be significant contributors to speeding up that evolutionary change, though changes in
regional or commodity competitive advantage could lead to significant structural changes in the
future. The benefits of biotechnology are going to be shared, with the consumer being the
primary beneficiary, though often being skeptical and alarmed about biotechnology. The
farmer first-adopter will be the temporary beneficiary, with other farmers continuing on the
technological treadmill. The biotech companies will share the benefits for their research and
development investments in a risky and uncertain new technology. Environmental benefits may
also accrue, though the effects will have to be evaluated on an ad hoc basis.
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Finally, we reviewed several approaches to evaluating the impact of new biotechnologies
before they become available, and conclude that there are several approaches which can be
used to estimate likely implications on new technologies before they are introduced, though
very few have been done to date that are sufficiently comprehensive. This will be an
extremely important area for social scientists interested.in the food and agricultural sector and
rural communities during the next two decades.
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